Vistagen Therapeutics Inc (VTGN)

$4.75 0.05 (1.06%)

16:00 EDT VTGN Stock Quote Delayed 30 Minutes

7 Stocks Under $15 Predicted to Boom in the Next 2 Years

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 19, 2024

Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.

Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027

Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027

3 Revolutionary Biotech Stocks Poised for 10X Surge

More Articles

Volume:

Previous Close -

Market Cap 44.47M

PE Ratio -95.00

EPS -0.05

Volume (Avg. Vol.) 194,533

Day's Range $4.65 - $4.85

52-Week Range $1.62 - $24.71

Dividend & Yield N/A (N/A)

VTGN Stock Predictions, Articles, and Vistagen Therapeutics Inc News

From InvestorPlace
From the Web

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave

By Shane Neagle, InvestorPlace Contributor Feb 14, 2024

Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.

3 Penny Stocks to Buy for the Next Bull Run: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 7, 2024

As the market pivots in 2024, dive into the dynamic world of penny stocks, revealing the top choices for February's exhilarating bull run.

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

By Michael Que, InvestorPlace Contributor Jan 26, 2024

With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Oct 17, 2023

It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!

The 7 Best Short-Squeeze Stocks to Buy Now: September 2023

By Josh Enomoto, InvestorPlace Contributor Sep 21, 2023

Explore the potential of the best short-squeeze stocks to buy now as companies attempt to prove pessimistic traders wrong.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Aug 10, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!

Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today?

By Samuel O'Brient, InvestorPlace Reporter Aug 7, 2023

Vistagen Therapeutics has reported positive Phase 3 trial results for a social anxiety treatment. VTGN stock is skyrocketing as a result.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Feb 14, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Sep 12, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them.

7 Cheap Biotech Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor May 19, 2022

These biotech stocks are speculative, but could potentially blow up in the next couple of years with new treatments in the pipelines.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 1, 2021

Good morning, investor! We're starting the day off with a deep dive into the biggest pre-market stock movers for Thursday!

7 A-Rated Biotech Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff Jun 15, 2021

Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer May 20, 2021

Welcome back again, investors, and let's get ready for a busy day of trading with a look at the biggest pre-market stock movers for Thursday!

7 Robinhood Stocks To Buy for Your Penny Stocks Portfolio

By Chris Markoch, InvestorPlace Contributor Mar 5, 2021

Robinhood has attracted a new group of traders to penny stocks. And with a little bit of homework, these seven penny stocks could have real upside.

Why Vistagen Therapeutics Inc Stock Is Going Wild Today

By William White, InvestorPlace Writer May 25, 2018

Vistagen Therapeutics (VTGN) stock was flying high on Friday following news that it is being covered by another research firm,

Vistagen Therapeutics files for $350M mixed shelf (NASDAQ:VTGN)

From Seeking Alpha Feb 13, 2024

Vistagen Therapeutics files a prospectus for mixed shelf offering of up to $350M, but it's not an offer to sell securities.

Vistagen shares move up after Jefferies upgrade (NASDAQ:VTGN)

From Seeking Alpha Dec 7, 2023

Vistagen Therapeutics (VTGN) sees a boost in stock after Jefferies raises it to Buy, citing positive results from a Phase 3 study of its social anxiety...

Vistagen shares move up after Jeffries upgrade (NASDAQ:VTGN)

From Seeking Alpha Dec 7, 2023

Vistagen Therapeutics (VTGN) sees a boost in stock after Jefferies raises it to Buy, citing positive results from a Phase 3 study of its social anxiety...

Vistagen stock climbs as Stifel starts at Buy (NASDAQ:VTGN)

From Seeking Alpha Nov 14, 2023

Vistagen Therapeutics (VTGN) stock rises as Stifel initiates its coverage with a Buy rating, highlighting its anxiety treatment candidate,fasedienol. Read more here.

Vistagen prices $100M underwritten offering (NASDAQ:VTGN)

From Seeking Alpha Oct 2, 2023

Vistagen Therapeutics (NASDAQ:VTGN) has priced $100M underwritten offering at a combined purchase price of $5.38 per share of common stock, accompanying T1...

Maxim Group Sticks to Its Hold Rating for VistaGen Therapeutics (VTGN)

From TipRanks Dec 7, 2022

Maxim Group analyst Jason McCarthy maintained a Hold rating on VistaGen Therapeutics (VTGN – Research Report) yesterday. The company’s shares opene...

ADVERTISEMENT